Compounds > deferoxamine

deferoxamine and dihydropyridines

deferoxamine has been researched along with dihydropyridines in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19905 (33.33)18.7374
1990's6 (40.00)18.2507
2000's1 (6.67)29.6817
2010's3 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baker, E; Jacobs, A; Peter, H; Wong, A1
Cook, EP; Fragonas, JC; Hunt, NH1
Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J1
Bierer, BE; Nathan, DG1
Chaudhri, G; Clark, IA1
Finger, J; Hegsted, M; Nathan, DG; Nicolosi, RJ; Peter, H; Renaud, MM; Wolfe, LC1
Baquet, A; Crichton, RR; Florence, A; Jin, Y; Schneider, YJ1
Beaudoin, RL; Gentilini, M; Guillouzo, A; Landau, I; Langlois, P; Mazier, D; Mellouk, S; Miltgen, F; Stahel, E1
Crichton, RR; Longueville, A1
Bergeron, RJ; Creary, EA; Daniels, RD; King, W; Luchetta, G; Moerker, T; Peter, HH; Streiff, RR; Wiegand, J1
Bergeron, RJ; Ratliff-Thompson, K; Weimar, WR; Wiegand, J1
Baker, E; Chua, AC; Kicic, A1
Chattipakorn, N; Chattipakorn, S; Chinda, K; Fucharoen, S; Kumfu, S1
Chattipakorn, N; Chattipakorn, S; Fucharoen, S; Kumfu, S1
Chattipakorn, N; Chattipakorn, SC; Fucharoen, S; Kumfu, S1

Other Studies

15 other study(ies) available for deferoxamine and dihydropyridines

ArticleYear
Desferrithiocin is an effective iron chelator in vivo and in vitro but ferrithiocin is toxic.
    British journal of haematology, 1992, Volume: 81, Issue:3

    Topics: Administration, Oral; Animals; Aspartate Aminotransferases; Cells, Cultured; Deferoxamine; Dihydropyridines; Dose-Response Relationship, Drug; Injections, Subcutaneous; Iodine Radioisotopes; Iron; Iron Chelating Agents; Iron Radioisotopes; Liver; Rats; Rats, Wistar; Thiazoles; Time Factors; Transferrin; Weight Gain

1992
Interference with oxidative processes inhibits proliferation of human peripheral blood lymphocytes and murine B-lymphocytes.
    International journal of immunopharmacology, 1991, Volume: 13, Issue:7

    Topics: Animals; B-Lymphocytes; Deferoxamine; Dihydropyridines; DNA; Ferricyanides; Humans; In Vitro Techniques; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Oxidation-Reduction; Oxygen; T-Lymphocytes; Thiazoles

1991
A comparative evaluation of iron clearance models.
    Annals of the New York Academy of Sciences, 1990, Volume: 612

    Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles

1990
The effect of desferrithiocin, an oral iron chelator, on T-cell function.
    Blood, 1990, Nov-15, Volume: 76, Issue:10

    Topics: Antigens, Surface; Calcium; Cell Division; Cell Membrane; Cells, Cultured; Cytotoxicity, Immunologic; Deferoxamine; Dihydropyridines; Humans; Interleukin-2; Iron; Iron Chelating Agents; Killer Cells, Natural; Lymphocyte Activation; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Thiazoles

1990
Reactive oxygen species facilitate the in vitro and in vivo lipopolysaccharide-induced release of tumor necrosis factor.
    Journal of immunology (Baltimore, Md. : 1950), 1989, Aug-15, Volume: 143, Issue:4

    Topics: Animals; Antioxidants; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Deferoxamine; Dihydropyridines; Free Radicals; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred CBA; Oxygen; Peritoneal Cavity; Thiazoles; Tumor Necrosis Factor-alpha

1989
A non-human primate model for the study of oral iron chelators.
    British journal of haematology, 1989, Volume: 72, Issue:3

    Topics: Administration, Oral; Animals; Cebus; Deferoxamine; Dihydropyridines; Disease Models, Animal; Injections, Intramuscular; Iron; Iron Chelating Agents; Thiazoles

1989
Desferrithiocin and desferrioxamine B. Cellular pharmacology and storage iron mobilization.
    Biochemical pharmacology, 1989, Oct-01, Volume: 38, Issue:19

    Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Iron; Liver; Male; Rats; Rats, Inbred Strains; Thiazoles; Tritium

1989
Iron chelators: in vitro inhibitory effect on the liver stage of rodent and human malaria.
    The American journal of tropical medicine and hygiene, 1988, Volume: 39, Issue:3

    Topics: Animals; Cells, Cultured; Deferoxamine; Dihydropyridines; Humans; Iron Chelating Agents; Liver; Malaria; Microscopy, Electron; Plasmodium falciparum; Plasmodium yoelii; Rats; Thiazoles

1988
An animal model of iron overload and its application to study hepatic ferritin iron mobilization by chelators.
    Biochemical pharmacology, 1986, Nov-01, Volume: 35, Issue:21

    Topics: Administration, Oral; Animals; Body Weight; Chelating Agents; Deferoxamine; Dihydropyridines; Ferritins; Ferrous Compounds; Injections, Intraperitoneal; Liver; Male; Metallocenes; Organ Size; Organometallic Compounds; Pyridines; Rats; Rats, Inbred Strains; Thiazoles

1986
A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.
    Blood, 1993, Apr-15, Volume: 81, Issue:8

    Topics: Animals; Cebus; Deferoxamine; Dihydropyridines; Feces; Gastrointestinal Diseases; Iron; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Siderophores; Thiazoles

1993
The origin of the differences in (R)- and (S)-desmethyldesferrithiocin. Iron-clearing properties.
    Annals of the New York Academy of Sciences, 1998, Jun-30, Volume: 850

    Topics: Animals; Cebus; D-Amino-Acid Oxidase; Deferoxamine; Dihydropyridines; Iron; Iron Chelating Agents; Kinetics; Male; Metabolic Clearance Rate; Molecular Structure; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Thiazoles

1998
Desferrithiocin is a more potent antineoplastic agent than desferrioxamine.
    British journal of pharmacology, 2002, Volume: 135, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Fibroblasts; Hepatocytes; Humans; Iron; Iron Chelating Agents; Male; Mice; Rats; Rats, Wistar; Thiazoles; Tumor Cells, Cultured

2002
T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
    European journal of haematology, 2012, Volume: 88, Issue:6

    Topics: Animals; Azoles; Base Sequence; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular System; Deferoxamine; Dihydropyridines; Disease Models, Animal; DNA Primers; Heart Rate; Humans; Iron; Iron Chelating Agents; Iron, Dietary; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Nifedipine; Nitrophenols; Organ Size; Organophosphorus Compounds; Organoselenium Compounds; RNA, Messenger; Ventricular Function, Left; Verapamil

2012
Ferric iron uptake into cardiomyocytes of β-thalassemic mice is not through calcium channels.
    Drug and chemical toxicology, 2013, Volume: 36, Issue:3

    Topics: Animals; Azoles; beta-Thalassemia; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, T-Type; Cation Transport Proteins; Cell Survival; Cells, Cultured; Deferoxamine; Dihydropyridines; Disease Models, Animal; Ferric Compounds; Heart Ventricles; Iron Overload; Isoindoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocytes, Cardiac; Nitrophenols; Organophosphorus Compounds; Organoselenium Compounds; Quaternary Ammonium Compounds; Receptors, Transferrin; Verapamil

2013
Dual T-type and L-type calcium channel blocker exerts beneficial effects in attenuating cardiovascular dysfunction in iron-overloaded thalassaemic mice.
    Experimental physiology, 2016, Volume: 101, Issue:4

    Topics: Animals; Benzoates; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cardiovascular Diseases; Deferasirox; Deferiprone; Deferoxamine; Dihydropyridines; Heart; Iron Chelating Agents; Iron Overload; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Mitochondria; Nitrophenols; Organophosphorus Compounds; Pyridones; Thalassemia; Triazoles

2016